share_log

Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit

Cabot's (NYSE:CBT) Shareholders May Want To Dig Deeper Than Statutory Profit

卡博特(紐約證券交易所代碼:CBT)的股東可能希望獲得比法定利潤更深入的挖掘
Simply Wall St ·  05/13 06:52

Following the solid earnings report from Cabot Corporation (NYSE:CBT), the market responded by bidding up the stock price. Despite this, our analysis suggests that there are some factors weakening the foundations of those good profit numbers.

繼卡博特公司(紐約證券交易所代碼:CBT)發佈穩健的收益報告之後,市場的回應是提高了股價。儘管如此,我們的分析表明,有一些因素削弱了這些良好利潤數字的基礎。

earnings-and-revenue-history
NYSE:CBT Earnings and Revenue History May 13th 2024
紐約證券交易所:CBT 收益和收入歷史記錄 2024 年 5 月 13 日

How Do Unusual Items Influence Profit?

不尋常的物品如何影響利潤?

For anyone who wants to understand Cabot's profit beyond the statutory numbers, it's important to note that during the last twelve months statutory profit gained from US$57m worth of unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we crunched the numbers on thousands of publicly listed companies, we found that a boost from unusual items in a given year is often not repeated the next year. And that's as you'd expect, given these boosts are described as 'unusual'. Assuming those unusual items don't show up again in the current year, we'd thus expect profit to be weaker next year (in the absence of business growth, that is).

對於任何想了解卡博特在法定數字之外的利潤的人來說,值得注意的是,在過去的十二個月中,從價值5700萬美元的不尋常物品中獲得了法定利潤。我們不能否認更高的利潤通常會讓我們感到樂觀,但如果利潤是可持續的,我們更願意這樣做。當我們計算數千家上市公司的數字時,我們發現,特定年份中不尋常的項目所帶來的提振通常不會在第二年重演。這正如你所預料的那樣,因爲這些增強被描述爲 “不尋常”。假設這些不尋常的項目在本年度不會再次出現,因此我們預計明年的利潤將疲軟(也就是說,在業務沒有增長的情況下)。

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

這可能會讓你想知道分析師對未來盈利能力的預測。幸運的是,您可以單擊此處查看根據他們的估計描繪未來盈利能力的交互式圖表。

Our Take On Cabot's Profit Performance

我們對卡博特盈利表現的看法

Arguably, Cabot's statutory earnings have been distorted by unusual items boosting profit. Therefore, it seems possible to us that Cabot's true underlying earnings power is actually less than its statutory profit. But at least holders can take some solace from the 42% EPS growth in the last year. Of course, we've only just scratched the surface when it comes to analysing its earnings; one could also consider margins, forecast growth, and return on investment, among other factors. So while earnings quality is important, it's equally important to consider the risks facing Cabot at this point in time. For example, we've discovered 2 warning signs that you should run your eye over to get a better picture of Cabot.

可以說,卡博特的法定收益被提高利潤的不尋常項目所扭曲。因此,在我們看來,卡博特的真正潛在盈利能力實際上可能低於其法定利潤。但是,至少持有人可以從去年42%的每股收益增長中得到一些安慰。當然,我們只是在分析其收益時才浮出水面;人們還可以考慮利潤率、預測增長和投資回報率等因素。因此,儘管收益質量很重要,但考慮卡博特目前面臨的風險同樣重要。例如,我們發現了兩個警告信號,爲了更好地了解卡博特,你應該仔細看看。

Today we've zoomed in on a single data point to better understand the nature of Cabot's profit. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.

今天,我們放大了單個數據點,以更好地了解卡博特利潤的性質。但是,如果你能夠將注意力集中在細節上,總會有更多的事情需要發現。有些人認爲高股本回報率是優質業務的好兆頭。因此,你可能希望看到這份免費收藏的擁有高股本回報率的公司,或者這份內部人士正在購買的股票清單。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論